Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Research & Development (2018 - 2019)

Historic Research & Development for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to $1.8 million.

  • DiaMedica Therapeutics' Research & Development rose 2419.02% to $1.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $7.9 million, marking a year-over-year increase of 7470.15%. This contributed to the annual value of $19.1 million for FY2024, which is 4536.23% up from last year.
  • As of Q4 2019, DiaMedica Therapeutics' Research & Development stood at $1.8 million, which was up 2419.02% from $1.6 million recorded in Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Research & Development ranged from a high of $2.6 million in Q1 2019 and a low of $791000.0 during Q1 2018